Onyx Healthcare Inc. carries a market capitalization of 4.36B, placing it among publicly traded companies globally. Its enterprise value stands at 4.17B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 4.36B |
| Enterprise Value | 4.17B |
Onyx Healthcare Inc. currently has 39.07M shares outstanding.
| Shares Outstanding | 39.07M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Onyx Healthcare Inc. trades at a trailing price-to-earnings ratio of 54.51. The price-to-sales ratio is 4.33, and the price-to-book ratio stands at 7.21.
| PE Ratio | 54.51 |
| PS Ratio | 4.33 |
| PB Ratio | 7.21 |
| P/TBV Ratio | 2.71 |
| P/FCF Ratio | 40.82 |
| P/OCF Ratio | 44.51 |
On an enterprise value basis, Onyx Healthcare Inc. trades at an EV/EBITDA multiple of 81.56 and an EV/FCF ratio of 38.69. The EV/Sales ratio of 4.24 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 81.56 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.24 |
| EV / EBITDA | 81.56 |
| EV / EBIT | 81.56 |
| EV / FCF | 38.69 |
Onyx Healthcare Inc. maintains a current ratio of 2.17, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 18.65, indicating elevated leverage, while an interest coverage ratio of 14.27 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.17 |
| Quick Ratio | 1.00 |
| Debt / Equity | 18.65 |
| Debt / EBITDA | 5.73 |
| Interest Coverage | 14.27 |
Onyx Healthcare Inc. posts a return on equity of 12.69 and a return on invested capital of 2.53.
| Return on Equity (ROE) | 12.69 |
| Return on Assets (ROA) | 3.66 |
| Return on Invested Capital (ROIC) | 2.53 |
| Return on Capital Employed (ROCE) | 9.13 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.47 |
Over the trailing twelve months, Onyx Healthcare Inc. has paid 7.52M in income taxes, reflecting an effective tax rate of 8.80.
| Income Tax | 7.52M |
| Effective Tax Rate | 8.80 |
Onyx Healthcare Inc.'s stock has declined approximately -6.69456% over the past 52 weeks. The 50-day moving average sits at 98.67, while the 200-day moving average is 109.90.
| Beta (5Y) | N/A |
| 52-Week Price Change | -6.69456% |
| 50-Day Moving Average | 98.67 |
| 200-Day Moving Average | 109.90 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Onyx Healthcare Inc. generated 983.15M in revenue and converted that into 78.06M in net income, yielding earnings per share of 2.00. EBITDA reached 51.07M, while operating income came in at 51.07M.
| Revenue | 983.15M |
| Gross Profit | 334.33M |
| Operating Income | 51.07M |
| Pretax Income | 85.55M |
| Net Income | 78.06M |
| EBITDA | 51.07M |
| EBIT | 51.07M |
| Earnings Per Share (EPS) | 2.00 |
Onyx Healthcare Inc. holds 382.50M in cash and equivalents against 292.84M in total debt, resulting in a net debt position of -120.39M. Total book value stands at 590.04M, with working capital of 449.79M providing operational flexibility.
| Cash & Cash Equivalents | 382.50M |
| Total Debt | 292.84M |
| Net Debt | -120.39M |
| Equity (Book Value) | 590.04M |
| Book Value Per Share | 15.18 |
| Working Capital | 449.79M |
Onyx Healthcare Inc. produced 95.60M in operating cash flow over the past twelve months. After subtracting -8.79M in capital expenditures, free cash flow totaled 86.81M - equivalent to 2.23 per share.
| Operating Cash Flow | 95.60M |
| Capital Expenditures | -8.79M |
| Free Cash Flow | 86.81M |
| FCF Per Share | 2.23 |
Onyx Healthcare Inc. operates with a gross margin of 34.01, reflecting its pricing power and cost economics. The operating margin of 5.19 and net profit margin of 7.94 provide insight into operational efficiency.
| Gross Margin | 34.01 |
| Operating Margin | 5.19 |
| Pretax Margin | 8.70 |
| Profit Margin | 7.94 |
| EBITDA Margin | 5.19 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.55 |
| FCF Yield | 2.45 |
Onyx Healthcare Inc.'s most recent stock split took place on August 1, 2024 with a 1000:1149 split ratio.
| Last Split Date | 8/1/2024 |
| Split Ratio | 1000:1149 |
Onyx Healthcare Inc. posts an Altman Z-Score of 5.29, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.29 |